[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334835-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334835-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","ribosomal-dysregulation-in-metastatic-laryngeal-squamous-cell-carcinoma-proteomic-insights-and-cx-5461s-therapeutic-promise","Ribosomal Dysregulation in Metastatic Laryngeal Squamous Cell Carcinoma - Proteomic Insights and CX-5461’s Therapeutic Promise","","Postoperative progression driven by tumor metastasis remains a major barrier to successful laryngeal squamous cell carcinoma (LSCC) treatment. This study used TMT-based proteomics to compare cancerous and adjacent non-cancerous tissues from 10 LSCC patients with lymph node metastasis and 10 without, quantifying 5545 proteins. It found 57 downregulated proteins enriched in cell adhesion pathways and 69 upregulated proteins enriched in protein production, with increased ribosomal activity strongly linked to lymph node metastasis, highlighting RPS10 and RPL24 as candidate biomarkers. The RNA polymerase I inhibitor CX-5461 disrupted ribosome biogenesis, reduced RPS10/RPL24/RPS26 expression, moderately decreased viability, and inhibited invasion and migration while promoting EMT reversal through upregulating CDH1 and suppressing CDH2, VIM, and FN. Overall, ribosome targeting is proposed as a supplementary therapeutic strategy for metastatic LSCC.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/ribosomal-dysregulation-in-metastatic-laryngeal-squamous-cell-carcinoma-proteomic-insights-and-cx-5461s-therapeutic-promise/334835/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/ribosomal-dysregulation-in-metastatic-laryngeal-squamous-cell-carcinoma-proteomic-insights-and-cx-5461s-therapeutic-promise/334835.png","ImageObject",300,407,{"name":42,"@type":43},"Ivy","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is lymph node metastasis important in metastatic LSCC outcomes?","Question",{"text":63,"@type":64},"The document states that metastasis at diagnosis is a critical prognostic factor. It notes that survival decreases with ipsilateral and contralateral/bilateral involvement and emphasizes metastasis features for assessing distant disease risk.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was proteomic profiling performed in this study?",{"text":68,"@type":64},"TMT-based proteomic analysis compared cancerous and adjacent non-cancerous tissues from 10 LSCC patients with lymph node metastasis and 10 without. A total of 5545 proteins were quantified across all samples.",{"name":70,"@type":61,"acceptedAnswer":71},"What does CX-5461 do to ribosomal activity and LSCC cell behavior?",{"text":72,"@type":64},"CX-5461 inhibits ribosome biogenesis by targeting RNA polymerase I, decreasing expression of ribosomal proteins such as RPS10, RPL24, and RPS26. It moderately reduces cell viability and significantly inhibits invasion and migration, while shifting EMT marker expression toward epithelial features.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334835,1790161584,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":4},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","toxics  \nArticle  \nRibosomal Dysregulation in Metastatic Laryngeal Squamous Cell Carcinoma: Proteomic Insights and CX-5461’s Therapeutic Promise  \nMiao Gao†, Ting Liu†, Kairui Hu, Songling Chen, Shixin Wang, Di Gan, Zhihan Li and Xiaohuang Lin *  \nCitation: Gao, M.; Liu, T.; Hu, K.; Chen, S.; Wang, S.; Gan, D.; Li, Z.; Lin, X. Ribosomal Dysregulation in Metastatic Laryngeal Squamous Cell Carcinoma: Proteomic Insights and CX-5461’s Therapeutic Promise. Toxics 2024, 12, 363. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)toxics12050363  \nAcademic Editor: Youssef Sari  \nReceived: 13 March 2024  \nRevised: 9 May 2024  \nAccepted: 10 May 2024  \nPublished: 13 May 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nKey Laboratory of Ministry of Education for Gastrointestinal Cancer, School of Basic Medical Sciences,  \nFujian Medical University, Fuzhou 350108, China; [miaomiao055@163.com](miaomiao055@163.com) (M.G.); [liuting8026@fjmu.edu.cn](liuting8026@fjmu.edu.cn) (T.L.);  \n[hkr59625@fjmu.edu.cn](hkr59625@fjmu.edu.cn) (K.H.); [chensongling@fjmu.edu.cn](chensongling@fjmu.edu.cn) (S.C.); [wangshixin@stu.fjmu.edu.cn](wangshixin@stu.fjmu.edu.cn) (S.W.);  \n[gandi@stu.fjmu.edu.cn](gandi@stu.fjmu.edu.cn) (D.G.); [lizhihan@stu.fjmu.edu.cn](lizhihan@stu.fjmu.edu.cn) (Z.L.)  \n* Correspondence: [linxiaohuang@fjmu.edu.cn](linxiaohuang@fjmu.edu.cn)  \n† These authors contributed equally to this work.  \nAbstract: One of the main barriers to the successful treatment of laryngeal squamous cell carcinoma (LSCC) is postoperative progression, primarily due to tumor cell metastasis. To systematically investigate the molecular characteristics and potential mechanisms underlying the metastasis in laryngeal cancer, we carried out a TMT-based proteomic analysis of both cancerous and adjacent non-cancerous tissues from 10 LSCC patients with lymph node metastasis (LNM) and 10 without. A total of 5545 proteins were quantified across all samples. We identified 57 proteins that were downregulated in LSCC with LNM, which were enriched in cell adhesion pathways, and 69 upregulated proteins predominantly enriched in protein production pathways. Importantly, our data revealed a strong correlation between increased ribosomal activity and the presence of LNM, as 18 ribosomal subunit proteins were found to be upregulated, with RPS10 and RPL24 being the most significantly overexpressed. The potential of ribosomal proteins, including RPS10 and RPL24, as biomarkers for LSCC with LNM was confirmed in external validation samples (six with LNM and six without LNM) using Western blotting and immunohistochemistry. Furthermore, we have confirmed that the RNA polymerase I inhibitor CX-5461, which impedes ribosome biogenesis in LSCC, also decreases the expression of RPS10, RPL24, and RPS26 . In vitro experiments have revealed that CX-5461 moderately reduces cell viability, while it significantly inhibits the invasion and migration of LSCC cells. It can enhance the expression of the epithelial marker CDH1 and suppress the expression of the mesenchymal markers CDH2, VIM, and FN at a dose that does not affect cell viability. Our study broadens the scope of the proteomic data on laryngeal cancer and suggests that ribosome targeting could be a supplementary therapeutic strategy for metastatic LSCC.  \nKeywords: LSCC; Lymph node metastasis; Proteomics; Ribosome; CX-5461  \n1. Introduction  \nHead and neck cancers (HNCs) are ranked as the sixth most common type of cancer worldwide, they encompass a diverse range of tumors classified by their site of origin [1,2] . Laryngeal carcinoma (LC) represents a substantial fraction of HNCs, accounting for on","cbCaiapePI4TmIB6","https://ap.wps.com/l/cbCaiapePI4TmIB6","pdf",7736496,"English","# Introduction\n## Background on head and neck and laryngeal cancers\n## Role of lymph node metastasis in prognosis\n## Biological steps of lymph node metastasis\n## Biomarkers linked to metastatic progression\n## Study rationale","[{\"question\":\"Why is lymph node metastasis important in metastatic LSCC outcomes?\",\"answer\":\"The document states that metastasis at diagnosis is a critical prognostic factor. It notes that survival decreases with ipsilateral and contralateral/bilateral involvement and emphasizes metastasis features for assessing distant disease risk.\"},{\"question\":\"How was proteomic profiling performed in this study?\",\"answer\":\"TMT-based proteomic analysis compared cancerous and adjacent non-cancerous tissues from 10 LSCC patients with lymph node metastasis and 10 without. A total of 5545 proteins were quantified across all samples.\"},{\"question\":\"What does CX-5461 do to ribosomal activity and LSCC cell behavior?\",\"answer\":\"CX-5461 inhibits ribosome biogenesis by targeting RNA polymerase I, decreasing expression of ribosomal proteins such as RPS10, RPL24, and RPS26. It moderately reduces cell viability and significantly inhibits invasion and migration, while shifting EMT marker expression toward epithelial features.\"}]","Ribosomal Dysregulation in Metastatic Laryngeal Squamous Cell Carcinoma - Proteomic Insights and CX-5461’s Therapeutic Promise | PDF",1790008499,48]